As of 2025-03-21, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (14.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -165.0%.
The range of the Relative Valuation is (7.27) - (22.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.6x - 16.7x | 10.6x |
| Forward P/E multiples | 5.1x - 15.6x | 10.4x |
| Fair Price | (7.27) - (22.23) | (14.96) |
| Upside | -131.6% - -196.6% | -165.0% |
| Date | P/E |